Send to

Choose Destination
See comment in PubMed Commons below
J Clin Gastroenterol. 2002 Oct;35(4):315-20.

Factors associated with treatment failure of Helicobacter pylori infection in a developing country.

Author information

Laboratory of Research in Bacteriology, Facultade de Medicina, Universitdade Federal de Minas Gerais and Gastroenterology Division, Hospital Governador Israel Pinheiro, Belo Horizonte, Brazil.



Although no regimen can eradicate in 100% of patients, factors that may affect the eradication rates have been poorly studied.


To evaluate factors associated with treatment failure.


One hundred patients were treated with pantoprazole plus clarithromycin and furazolidone for eradication. Clarithromycin and furazolidone resistance was evaluated by the agar dilution method. Point mutations in 23S rRNA genes related to clarithromycin resistance were investigated by polymerase chain reaction and restriction length fragment polymorphism and A by polymerase chain reaction. The data were analyzed by logistic regression.


eradication occurred in 85 of 97 patients who completed the treatment (87.6%; 95% CI = 79.0-93.1). All strains were susceptible to furazolidone, and nine were resistant to clarithromycin (A2142G or A2143G mutation was detected in all of them). The treatment failure was significant and independently associated with clarithromycin resistance (OR = 7.79; 95% CI = 1.73-35.01), A-negative status (OR = 4.81; 95% CI = 1.14-20.14), and male gender (OR = 4.20; 95% CI = 1.01-17.78), but not with the type of disease, mean age, smoking, alcohol consumption, and the degree of the antral and oxyntic gastritis.


Resistance to clarithromycin, A-negative status, and gender were predictive factors of eradication failure.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center